SPOTLIGHT -
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction
Stacy Stein, MD, and co-investigators, research omalizumab to treat oxaliplatin hypersensitivity reactions for patients with gastrointestinal cancers.
